Gadolinium is a metallic chemical that is commonly injected into patients who are going to receive an MRI because it enhances the resulting image. It has recently been discovered that the gadolinium compound, when used in patients with kidney or liver problems, may cause a disease called nephrogenic systemic fibrosis (NSF). NSF is a debilitating disease in which fibrosis, or the formation of excessive connective tissue, occurs in the skin, joints, or internal organs of the afflicted individual. There is no known cure for NSF, and the continuing swelling and hardening of skin, joints, and organs can lead to death.
In 2007, the FDA directed manufacturers of gadolinium-based MRI contrast agents to include a black box warning informing patients about the risk of NSF. A black box is the highest warning required by the FDA, and it signifies that a drug carries a significant risk of serious or life-threatening adverse events.
If you or someone you know has undergone an MRI and is experiencing skin hardening, development of lesions, or deep joint pain, a doctor should be consulted to determine whether or not the symptoms are caused by NSF.
Individuals suffering from NSF may be entitled to monetary compensation for their injuries and suffering. If you would like to speak with a lawyer about your potential right to recover damages,
please
contact one of our Gadolinium attorneys and we will set up a free consultation.